menu
    • menu

    Company profile for Provectus Biopharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Provectus Biopharmaceuticals is developing a new class of drugs based on halogenated xanthenes like Rose Bengal. Intralesional PV-10, the first small molecule oncolytic immunotherapy, is undergoing clinical study for adult solid tumor cancers like melanoma and cancers of the liver, and preclinical study for pediatric cancers. Topical PH-10 is undergoing clinical study for inflammatory dermatoses like psoriasis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Provectus BiopharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Provectus Biopharmaceuticals, Inc. 10025 Investment Dr., Suite 250 Knoxville, ...
    Telephone
    Telephone
    +1 (866) 594-5999
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.provectusbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Provectus Bio Positions PV-10 As Unique Vaccine Adjuvant
    Provectus Bio Positions PV-10 As Unique Vaccine Adjuvant

    09 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/09/3164100/0/en/Provectus-Biopharmaceuticals-Positions-PV-10-as-a-Differentiated-Alternative-to-Traditional-Vaccine-Adjuvants-University-of-Calgary-Research-Highlights-Novel-STING-Pathway-Activati.html

    GLOBENEWSWIRE
    09 Oct 2025
    Share Share
    Provectus Begins Preclinical Study Of Pv-10 For Bladder Cancer
    Provectus Begins Preclinical Study Of Pv-10 For Bladder Cancer

    29 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/29/3157674/0/en/Provectus-Biopharmaceuticals-Initiates-Preclinical-Study-of-Oral-PV-10-in-Bladder-Cancer.html

    GLOBENEWSWIRE
    29 Sep 2025
    Share Share
    Provectus Shares PV-10 Head & Neck Cancer Data
    Provectus Shares PV-10 Head & Neck Cancer Data

    26 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/26/3105781/0/en/Provectus-Biopharmaceuticals-Announces-Publication-of-Moffitt-Cancer-Center-Research-on-PV-10-for-Head-and-Neck-Cancer.html

    GLOBENEWSWIRE
    26 Jun 2025
    Share Share
    Provectus Biopharmaceuticals Investor Webinar for 2025 Meeting
    Provectus Biopharmaceuticals Investor Webinar for 2025 Meeting

    09 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/09/3095800/0/en/Provectus-Biopharmaceuticals-Announces-Investor-Webinar-for-2025-Annual-Meeting-of-Stockholders.html

    GLOBENEWSWIRE
    09 Jun 2025
    Share Share
    Provectus Launch VisiRose for Rose Bengal-Based Drug Development
    Provectus Launch VisiRose for Rose Bengal-Based Drug Development

    14 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/14/3009222/0/en/Provectus-Biopharmaceuticals-Announces-Seed-Financing-for-VisiRose-Provectus-s-Spinoff-Company-for-Rose-Bengal-Based-Eye-Drugs.html

    GLOBENEWSWIRE
    14 Jan 2025
    Share Share
    Provectus BioPharma Launches VisiRose for Ophthalmology Treatments
    Provectus BioPharma Launches VisiRose for Ophthalmology Treatments

    11 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/11/2995461/0/en/Provectus-Biopharmaceuticals-Launches-VisiRose-Provectus-s-Founded-Entity-for-Pharmaceutical-grade-Rose-Bengal-Sodium-based-Treatments-in-Ophthalmology.html

    GLOBENEWSWIRE
    11 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search